CARBIDOPA, LEVODOPA AND ENTACAPONE
Active substance: CARBIDOPA, LEVODOPA, ENTACAPONE
TABLET, FILM COATED · CARBIDOPA 18.75 mg/1, LEVODOPA 75 mg/1, ENTACAPONE 200 mg/1
United StatesActive
Marketing holder: Rising Pharma Holdings, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- CARBIDOPA · 18.75 mg/1
- LEVODOPA · 75 mg/1
- ENTACAPONE · 200 mg/1
Registration
- Registration number
- 16571-690
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 16571-690 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 16571-690 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 16571-690 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 16571-690 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 16571-690 · Verified 2026-10-09 · open in source